Results 11 to 20 of about 3,444 (87)

68Ga-PSMA-11 PET/CT双时相SUVmax与前列腺癌临床病理特征的相关性

open access: yesZhongshan Daxue xuebao. Yixue kexue ban, 2021
目的探讨 68Ga-PSMA-11 PET/CT双时相前列腺癌原发病灶最大标准摄取值(SUVmax)与初诊前列腺癌患者各项临床病理特征的相关性。方法回顾性收集我院2017年11月至2020年9月期间初次确诊为前列腺癌的患者,共19例,年龄(69.0±7.4)岁。所有患者均行68Ga-PSMA-11 PET/CT双时相检查,检查后两周内均行前列腺癌根治术。通过阈值自动分割法,计算出前列腺癌原发病灶在标准相SUVmax1、延迟相SUVmax2、双时相SUVmax差值SUVmax3。收集所有病人的临床 ...
李建芳   +7 more
doaj  

Correlation analysis of PSMA PET/CT-derived parameters and circulating tumor DNA features in patients with hormone-sensitive prostate cancer [PDF]

open access: yes
Background and purpose: Both prostate-specific membrane antigen (PSMA) positron emission tomography/computed tomography (PET/CT) and circulating tumor DNA (ctDNA) sequencing outcomes serve as references for therapeutic decision-making in hormone ...
PAN Jian, YE Dingwei, ZHU Yao, WANG Beihe
core   +1 more source

Expert consensus of 177Lu-labeled PSMA radioligand therapy for clinical practice of prostate cancer (2024 edition) [PDF]

open access: yes
177Lu-labeled prostate-specific membrane antigen radioligand therapy (177Lu-PSMA-RLT) is an innovative treatment approach that precisely delivers β radiation emitted by 177Lu to prostate cancer cells, causing radiation damage to the tumor cells’ DNA and ...
Cancer Nuclear Medicine Committee of China Anti-Cancer Association, Chinese Association of Nuclear Medicine Physicians
core   +1 more source

The unique value and controversy of nuclear medicine molecular imaging in the evaluation of radioiodine-refractory differentiated thyroid cancer [PDF]

open access: yes
Nuclear medicine molecular imaging has the characteristics of non-invasiveness, high sensitivity, spatiotemporal dynamic visualization, qualitative and quantitative analysis, and by virtue of the advantages of fusion imaging technology, it combines the ...
WANG Renfei, LU Gaixia
core   +1 more source

Progress and prospect on treatment for radioiodine-refractory thyroid cancer [PDF]

open access: yes
Most patients with differentiated thyroid cancer benefit from surgery, radioactive iodine-131 therapy and TSH suppression therapy, resulting in a favorable prognosis.
GENG Qianqian, YANG Aimin
core   +1 more source

Innovations and Challenges in Molecular Probe-Based Precision Theranostics for Genitourinary System Tumors [PDF]

open access: yes
Genitourinary system tumors, as a major clinical challenge posing a serious threat to human health, urgently require breakthroughs in the construction of a precision diagnosis and treatment system.
Mingwei SUN, Pengyu GUO, Wanhai XU
core   +1 more source

Advances in novel imaging agents targeting fibroblast activation proteins [PDF]

open access: yes
Based on the high target-to-background ratio(TBR),new imaging agents targeting fibroblast activation protein(FAP)have shown better imaging effects in a variety of tumors.
WANG Ning, SHI Yizhen
core   +1 more source

鉴定AP-4是在非激素依赖型前列腺癌中上调L-plastin表达的转录因子 [PDF]

open access: yes, 2006
【目的】鉴定AP-4是在非激素依赖型前列腺癌中调控L-plastin表达的转录因子,进一步阐明非激素依赖型前列腺癌的发病机制。【方法】在鉴定L-plastin启动子近3’端-216到1序列片段存在明显的转录活性的基础上,利用TFSEARCH软件分析该片段的序列,寻找可能调控L-plastin表达的非甾体激素类转录因子,并用凝胶滞后实验和超滞后实验证实结合于该片段的转录因子,利用PCR定点突变法构建删除该转录因子结合位点的重组子,并检测切除该片段序列后荧光素酶活性 ...
尹心宝   +7 more
core  

The Research Progress of Monoclonal Antibody Labeled with 89Zr [PDF]

open access: yes
Zirconium-89 (89Zr) is a metallic positron-emitting radionuclide. The relatively long half-life and moderate energy making 89Zr especially suitable for the labeling of large biomolecules such as antibodies for radioimmuno-PET (positron emission ...
Fei DUAN, Hongyu LI, Zhanxiong XIAO
core   +1 more source

Home - About - Disclaimer - Privacy